You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
This project analyzes a randomized phase III clinical trial evaluating the efficacy and safety of panitumumab combined with FOLFOX4 chemotherapy as a first-line treatment for metastatic colorectal cancer (mCRC). It includes survival analysis, adverse event assessment, and statistical modeling based on patient KRAS status.